in vitro

Constructed using low-drug-absorbing plastics, Chip-R1 builds upon the core microfluidic design of Organ-Chips, offering researchers greater precision in predicting human drug responses. 

Induced pluripotent stem cell-derived microglia generated with precision cell reprogramming technology can create more reliable in vitro assays.

Automation, multiplexing, artificial intelligence, and more come together to build a better laboratory environment.  

User-friendly software connects instruments, consumables, services, and support, reducing manual steps and improving productivity in qPCR workflows.

Pre-mixed attachment factors provide a robust solution to streamlining cell culture workflows.

Discover a guide for optimizing CO₂ incubator monitoring.

Discover how the latest cell counting technology is reshaping a mundane task for the future.

A method for culturing the infectious stage of the Plasmodium lifecycle could increase malaria vaccine production efficiency by tenfold, study authors say.

This year, neuroscience researchers made important discoveries related to how neurodegeneration attacks the human brain, hooked cultured neurons up to machinery to teach them to play a video game, and more.

Researchers found that the ApoA1 protein can restore ALS epithelial cell survival in vitro.

The DishBrain system can send and receive electrophysiological signals to and from living neurons, training the cells to accomplish a task.

Discover reasons for avoiding low oxygen levels in cell cultures.

Researchers report they were able to make functional sperm in a dish, a feat previously only possible for mice.

A cost-effective 3-D organoid biobank provides a versatile translational research tool.

An animal component-free culture medium provides a safe and robust alternative for maintaining induced pluripotent stem cells.

Geckos injected with neural stem cells modified to block cartilage growth developed the skeletal and nervous components normally lacking from regrown tails.

The National Academies’ report touches on ethical issues raised by new technologies such as brain organoids and human-animal chimeras, and suggests that current regulatory oversight is sufficient.

The three-dimensional cell cultures are still in the development phase, but researchers are excited about their use to predict patients’ responses to various treatment options.

The lab-made organoids are fully functional, the team reports, and could aid the study of vascular-related diseases such as diabetes.